Experimental and Molecular Pathology

Papers
(The H4-Index of Experimental and Molecular Pathology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Tumour suppressor role of microRNA-335-5p in esophageal squamous cell carcinoma by targeting TTK (Mps1)80
Dexamethasone attenuates low-frequency brainwave disturbances following acute seizures induced by pentylenetetrazol in Wistar rats80
The development of an indel panel for microchimerism detection44
Effect of glycated HDL on oxidative stress and cholesterol homeostasis in a human bladder cancer cell line, J8243
Aberrant cell adhesiveness due to DNA hypermethylation of KLF11 in papillary urothelial carcinomas40
An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms33
HSPB8 promoted intrahepatic cholangiocarcinoma progression by enhancing epithelial-mesenchymal transition and autophagy29
Twenty-eight-day perfluorooctanoate exposure does not affect immune cell populations in naïve mice24
NK1 receptor antagonistic effect of 17-trifluoromethyl phenyl trinor prostaglandin F2α on the growth of human breast cancer cell line21
Expression of concern: “Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune encephalomyelitis” [Experimental and Molecular Pathology 97 (2014) 470–476]20
A review of the critical role of vitamin D axis on the immune system20
Daidzin suppresses melanogenesis through ERK and AKT signaling pathways mediated MITF proteasomal degradation20
Antihyperglycemic activity of L-norvaline and L-arginine in high-fat diet and streptozotocin-treated male rats16
Editorial Board15
Hyperinsulinemic male LEW.1WR1 rats show early signs of impaired liver metabolism15
Retraction notice to “Silencing circANKRD36 protects H9c2 cells against lipopolysaccharide-induced injury via up-regulating miR-138” [Experimental and Molecular Pathology 111 (2019) 104300]15
Editorial Board15
0.083988904953003